Sage Therapeutics Inc - Company Profile
Powered by 
All the data and insights you need on Sage Therapeutics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Sage Therapeutics Inc Strategy Report
- Understand Sage Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Sage Therapeutics Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| EP3392260B1 | Grant | NEUROAKTIVE 19-ALKOXY-17-SUBSTITUIERTE STEROIDE ZUR VERWENDUNG IN BEHANDLUNGSVERFAHREN | A61K31/56; A61K31/565; A61K31/566; A61K31/57; A61K31/573; A61K31/575; A61K31/58; A61P11/06; A61P23/00; A61P23/02; A61P25/00; A61P25/04; A61P25/06; A61P25/08; A61P25/14; A61P25/16; A61P25/18; A61P25/20; A61P25/22; A61P25/24; A61P25/28; A61P25/30; A61P25/32; A61P29/00; A61P43/00; A61P9/10; C07J1/00; C07J1/0011; C07J1/0018; C07J1/0029; C07J13/007; C07J21/00; C07J21/006; C07J21/008; C07J41/00; C07J41/0005; C07J41/0016; C07J41/005; C07J41/0094; C07J5/00; C07J5/0015; C07J51/00; C07J7/00; C07J7/002; C07J9/00; C07J9/005 | September 21, 2022 |
| AU2017297375B2 | Grant | C17, C20, and C21 substituted neuroactive steroids and their methods of use | A61P25/08; A61P25/18; A61P25/20; A61P25/28; A61P5/00; C07J1/0029; C07J1/0081; C07J1/0085; C07J17/00; C07J41/0005; C07J41/0011; C07J41/005; C07J41/0066; C07J41/0094; C07J43/003; C07J7/002; C07J9/00 | September 15, 2022 |
| EP3258939B1 | Grant | NEUROAKTIVE STEROIDE, ZUSAMMENSETZUNGEN UND VERWENDUNGEN DAVON | A61K31/58; A61K45/06; A61P25/00; A61P25/20; A61P25/26; C07J13/007; C07J21/008; C07J43/003; C07J7/002; C07J7/007; C07J7/0085 | September 07, 2022 |
| HRP20170716T1 | Grant | OXYSTEROLS AND METHODS OF USE THEREOF | A61K31/575; A61K31/58; A61P1/00; A61P25/00; A61P25/20; A61P3/06; A61P3/10; A61P35/00; C07J17/00; C07J43/003; C07J9/00 | September 02, 2022 |
| AU2021200205B2 | Grant | Neuroactive steroids and methods of use thereof | A61K31/575; A61P1/14; A61P23/00; A61P25/00; A61P25/04; A61P25/08; A61P25/14; A61P25/16; A61P25/18; A61P25/20; A61P25/22; A61P25/24; A61P25/28; A61P25/30; A61P27/16; A61P29/00; A61P3/04; A61P43/00; A61P9/00; A61P9/10; C07J13/005; C07J13/007; C07J21/008; C07J41/0061; C07J9/00; C07J9/005 | September 01, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer